TBRG

NEUTRALM&A

TruBridge, Inc.

2026-06-16

Price

$26.12

+0.00%

This is the 2026-06-16 snapshot — the signals and analysis for TBRG as of this single trading day.

View full TBRG research hub →

Score12.5Priority

Signals5/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

The price action in TruBridge (TBRG) is entirely dictated by its pending acquisition by IKS Health for $26.25 per share in cash. The stock's ultra-low 2.0% annualized volatility and algorithmic signals like QUIET_STORM and STEADY_CLIMB perfectly reflect a classic merger arbitrage pinning effect, as shares drift sideways just below the buyout price. Furthermore, the robust RISK_ON macro regime and historically tight high-yield credit spreads provide supreme institutional confidence that the acquirer's financing is secure, rendering recent shareholder lawsuits as immaterial noise.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSPERFECT STACKSELLER FATIGUEWEAK FINISH

Key Takeaways

Actionable Thesis: TBRG is a pure merger arbitrage play, anchored at $26.12 with a high-probability path to the $26.25 cash acquisition price.
Key Risk: A sudden collapse in the M&A deal due to unexpected regulatory hurdles or an unforeseen financing failure from the acquirer.
What to Watch: Monitor the $25.86 support level to ensure the deal spread doesn't widen, alongside any updates on shareholder votes or regulatory approvals.

← Back to 2026-06-16 View Full TBRG History →Yahoo Finance &nearr;